AMNEAL PHARMACEUTICALS, INC. (AMRX) Capital expenditures 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$70.1MFY2025 · since FY2016: $122.8M → $70.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $70.1M | +34.9% |
| FY2024 | $51.9M | +20.1% |
| FY2023 | $43.2M | -6.9% |
| FY2022 | $46.4M | -2.8% |
| FY2021 | $47.7M | -15.4% |
| FY2020 | $56.4M | +19.6% |
| FY2019 | $47.2M | -43.2% |
| FY2018 | $83.1M | -12.3% |
| FY2017 | $94.8M | -22.8% |
| FY2016 | $122.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice